Jury Orders Biogen To Pay $5.9M For Retaliation, Sex Discrimination Claims
SEATTLE — A Washington federal jury on Nov. 11 found that drug maker Biogen Inc. retaliated against a saleswoman in violation of the federal False Claims Act, 31 U.S. Code §...To view the full article, register now.
Already a subscriber? Click here to view full article